Ultrathin hydrocolloid dressing in skin damaged from alternating radiotherapy and chemotherapy plus cetuximab in advanced head and neck cancer (G.O.N.O. AlteRCC Italian Trial): in regard to Macmillan et al. (Int J Radiat Oncol Biol Phys 2007;68:864-872).
Russi
Elvio G
EG
Merlano
Marco C
MC
Comino
Alberto
A
Numico
Gianmauro
G
D002266:Carboxymethylcellulose Sodium / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000737:chemistry / Q000627:therapeutic use*; D006801:Humans; D020100:Hydrogels / Q000737:chemistry / Q000627:therapeutic use*; D009779:Occlusive Dressings; D011855:Radiodermatitis / Q000628:therapy*; D016896:Treatment Outcome; D014945:Wound Healing
D003879:Dermatologic Agents; D020100:Hydrogels; D002266:Carboxymethylcellulose Sodium